Masaki Ishida

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Particulate Matter

Tyrosine Kinase

Cross Sectional

Top Venues

Thoracic cancer

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Masaki Ishida, Masahiro Iwasaku, Toshifumi Doi, Takeshi Ishikawa, Yusuke Tachibana, Ryo Sawada, Yuri Ogura, Hayato Kawachi, Yuki Katayama, Naoya Nishioka, Kenji Morimoto, Shinsaku Tokuda, Tadaaki Yamada, Koichi Takayama
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer. Cancer science 115 (5) (2024)
Masaki Ishida, Masahiro Iwasaku, Toshifumi Doi, Takeshi Ishikawa, Yusuke Tachibana, Ryo Sawada, Yuri Ogura, Hayato Kawachi, Yuki Katayama, Naoya Nishioka, Kenji Morimoto, Shinsaku Tokuda, Tadaaki Yamada, Koichi Takayama
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer. Cancer science 115 (5) (2024)
Yohei Matsui, Tadaaki Yamada, Yuki Katayama, Soichi Hirai, Ryo Sawada, Yusuke Tachibana, Masaki Ishida, Hayato Kawachi, Ryota Nakamura, Naoya Nishioka, Kenji Morimoto, Masahiro Iwasaku, Mano Horinaka, Toshiyuki Sakai, Shinsaku Tokuda, Koichi Takayama
Initial AXL and MCL-1 inhibition contributes to abolishing lazertinib tolerance in EGFR-mutant lung cancer cells. Cancer science (2024)
Masaki Ishida, Masahiro Iwasaku, Toshifumi Doi, Takeshi Ishikawa, Yusuke Tachibana, Ryo Sawada, Yuri Ogura, Hayato Kawachi, Yuki Katayama, Naoya Nishioka, Kenji Morimoto, Shinsaku Tokuda, Tadaaki Yamada, Koichi Takayama
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer. Cancer science (2024)
Masaki Ishida, Masahiro Iwasaku, Toshifumi Doi, Takeshi Ishikawa, Yusuke Tachibana, Ryo Sawada, Yuri Ogura, Hayato Kawachi, Yuki Katayama, Naoya Nishioka, Kenji Morimoto, Shinsaku Tokuda, Tadaaki Yamada, Koichi Takayama
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer. Cancer science 115 (5) (2024)
Tae Hata, Chikara Sakaguchi, Keita Hirano, Hiroshi Kobe, Masaki Ishida, Takayuki Nakano, Yusuke Tachibana, Nobuyo Tamiya, Shinsuke Shiotsu, Takayuki Takeda, Tadaaki Yamada, Toshihide Yokoyama, Michiko Tsuchiya, Yukio Nagasaka
Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR-TKI in non-small cell lung cancer patients with EGFR mutation: A multicenter retrospective study. Thoracic cancer (2023)
Soichi Hirai, Tadaaki Yamada, Yuki Katayama, Masaki Ishida, Hayato Kawachi, Yohei Matsui, Ryota Nakamura, Kenji Morimoto, Mano Horinaka, Toshiyuki Sakai, Yoshitaka Sekido, Shinsaku Tokuda, Takayama Koichi
Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells. Molecular cancer therapeutics (2023)
Masaki Ishida, Kenji Morimoto, Tadaaki Yamada, Shinsuke Shiotsu, Yusuke Chihara, Takahiro Yamada, Osamu Hiranuma, Yoshie Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Takayuki Takeda, Koichi Takayama
Impact of docetaxel plus ramucirumab in a second-line setting after chemoimmunotherapy in patients with non-small-cell lung cancer: A retrospective study. Thoracic cancer (2021)